Catherine Bresson, Director of Operational Team at WIN Consortium, shared a post on LinkedIn:
“WIN Consortium in cancer personalized medicine — Governance Election Update
We are pleased to announce that Wafik S. El-Deiry, has been re-elected as Chair of the WIN Consortium in cancer personalized medicine.
Warm congratulations to Apostolia M Tsimberidou, and Sewanti Limaye, on their election as Vice-Chairs of the WIN Consortium in cancer personalized medicine.”
Quoting Wafik S. El-Deiry:
“It’s a real honor and privilege for me to be re-elected by my peers and to continue the legacy of my predecessors as we take precision oncology to greater heights to benefit patients. The late Dr. John Mendelsohn who founded and led the WIN Consortium in cancer personalized medicine had the right motivation, vision for innovation, collaboration and global impact. That vision is as important today as it ever was and needs to be better realized. The WIN Consortium invites the community to reach out to collaborate and interact with an incredibly talented and growing community: Catherine Bresson, Razelle Kurzrock, Sewanti Limaye, Apostolia M Tsimberidou, Yves Lussier, Liang Cheng, Roy Herbst, Ruben Mesa, Gerald Batist, Benedito A. Carneiro, Jens Rueter, Joann Sweasy, William Dahut, William Oh, Vivek Subbiah, Steven Libutti, Don S. Dizon, Khaled Musallam, Humaid Al-Shamsi, Prof. Said Dermime, Charles Blanke, Brown University Health, Brown University, The Warren Alpert Medical School of Brown University, Ray DuBois, Rob Winn, Jennifer W. Pegher, National Cancer Institute (NCI).”
More posts featuring Wafik S. El-Deiry on OncoDaily.